Skip to content

Clinical trials

Metabolism, Inborn Errors trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20131
20141
20151
20172
20184
20191
20214
20221
20231
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting5
Active, not recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.5
Alexion Pharmaceuticals, Inc.3
Dr. Schär AG / SPA2
Kastle Therapeutics, LLC2
Vitaflo International, Ltd2
iECURE, Inc.2
Alnylam Pharmaceuticals1
HemoShear Therapeutics1
JCR Pharmaceuticals Co., Ltd.1
Manchester University NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors23
Genetic Diseases, Inborn15
Metabolic Diseases14
Amino Acid Metabolism, Inborn Errors5
Phenylketonurias5
Brain Diseases, Metabolic, Inborn4
Propionic Acidemia4
Brain Diseases3
Brain Diseases, Metabolic3
Central Nervous System Diseases3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.